Guidance for the use and prescribing of PCSK9 inhibitors

Primary care guidance for the prescribing and supply of Inclisiran

Inclisiran for the treatment of familial or non-familial hyperlipidaemia in secondary prevention of CVD

Summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease

NHS South West Strategic Clinical Network - Top tips for managing AF

Clinical guidelines for Secondary Prevention after Stroke or TIA

Inhixa (enoxaparin biosimilar) Information sheet

 

NICE Guidance on Drotrecogin alfa (activated) for severe sepsis (Issued Sept 2004, review date Sept 2007)
Drotrecogin alfa (activated) should be considered for adults with severe sepsis that has resulted in the failure of two or more major organs and who are receiving optimum intensive care support. Drotrecogin alfa (activated) should be initiated and supervised only by a specialist consultant with intensive care skills and experience in the care of patients with sepsis.